The most recent genetic study conducted in this population revealed lower than expected BRCA1/2 (1.7%) mutations, especially given the predominantly African ethnicity, whereas the highest reported to date for PALB2 (2.8%) among unselected BC patients (n = 179) [60]. This evidence concerns the gene PALB2 and breast cancer.